Skip to main content
. 2018 Aug 24;9(66):32580–32592. doi: 10.18632/oncotarget.25953

Figure 5. Hells has no effect on osteosarcoma tumorigenesis.

Figure 5

(AB) Kaplan–Meier curves showing the survival of osteosarcoma-prone mouse models. Loss of Hells in osteosarcoma-prone mice show no changes in overall survival in (A) Tp53/Rb1/Hells TKO: Osx-cre; Tp53lox/lox; Rb1lox/lox; Hells lox/lox (red; n = 23) compared to p53/Rb1 DKO: Osx-cre; Tp53lox/lox; Rb1lox/lox (black; n = 24) nor (B) p53/Hells DKO: Osx-cre; p53lox/lox; Hells lox/lox (red; n = 22) compared to p53 cKO: Osx-cre; p53lox/lox (black; n = 35). Mantel-Cox test and Mantel-Haenszel hazard ratio (HR) were used for curve comparisons. (C) Western blot detection of HELLS confirms loss of HELLS protein in p53/Rb1/Hells TKO mice and p53/Hells DKO mice and HELLS expression in p53/Rb1 DKO and p53 cKO osteosarcoma tumors.